Covered recipient · General Payments record
SMITA KUMAR
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$1,433.68
- Reported across 56 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $402.51 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $100.92 | 1 |
| Medtronic, Inc. | $63.98 | 3 |
| Novo Nordisk AS | $44.15 | 2 |
| Insulet Corporation | $41.88 | 2 |
| DEXCOM, INC. | $35.93 | 2 |
| Corcept Therapeutics | $22.71 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.08 | 1 |
| Kyowa Kirin, Inc. | $20.08 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.90 | 1 |
| CeQur Corporation | $17.68 | 1 |
| Tandem Diabetes Care, Inc. | $17.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $100.92 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115837347 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $20.08 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086172032 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.90 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118068012 | CMS |
| CeQur Corporation | $17.68 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126846074 | CMS |
| Corcept Therapeutics | $22.71 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117795118 | CMS |
| Dexcom, Inc. | $22.49 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153337007 | CMS |
| Dexcom, Inc. | $13.44 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153337009 | CMS |
| Insulet Corporation | $14.31 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116802726 | CMS |
| Insulet Corporation | $27.57 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116810587 | CMS |
| Kyowa Kirin, Inc. | $20.08 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127043285 | CMS |
| Medtronic, Inc. | $17.22 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119387084 | CMS |
| Medtronic, Inc. | $24.84 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119387086 | CMS |
| Medtronic, Inc. | $21.92 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119387088 | CMS |
| Novo Nordisk Inc | $16.95 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096917522 | CMS |
| Novo Nordisk Inc | $27.20 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097071836 | CMS |
| Tandem Diabetes Care, Inc. | $17.20 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138745099 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.